The Clinical Value of Innovation
(1) University of South Australia, Adelaide, Australia Abstract The term “innovation” is used in a number of different ways in pharmaceutical regulation processes. In this chapter I address the…
PHARMACY
The Shadow Price, λ
(1) University of South Australia, Adelaide, Australia Abstract In countries such as Australia, the UK and Canada, regulators are required to select a decision threshold that is a signal…
Reframing the Political Economy of New Drugs
(1) University of South Australia, Adelaide, Australia Abstract The first rule of the new drug reimbursement game is to recognise it is a game and that the regulator makes…
